Nestle India, Dr Reddy's to form joint venture for nutraceutical brands

This collaboration aims to expand their complementary nutraceutical portfolios in areas like metabolic care, hospital nutrition, general wellness, women's health, and child nutrition

Nestle
Anjali Singh Mumbai
2 min read Last Updated : Apr 25 2024 | 6:16 PM IST
Nestlé India and Dr. Reddy's Laboratories announced today that they have entered into a definitive agreement to form a joint venture (JV) to bring innovative nutraceutical brands to consumers in India and other agreed territories.

Under the agreement, Nestlé India and Dr. Reddy’s will combine their expertise and resources to form a new entity, the JV company. Headquartered in Hyderabad, this venture will merge Nestlé Health Science's global range of nutritional health solutions, vitamins, minerals, and supplements with Dr. Reddy's commercial presence in India.

This collaboration aims to expand their complementary nutraceutical portfolios in areas like metabolic care, hospital nutrition, general wellness, women's health, and child nutrition.

One of the strategies of the joint venture involves licensing select brands from both Nestlé and Dr. Reddy’s to the JV company. Nestlé will license brands such as Nature's Bounty, Osteo Bi-Flex, Ester-C, and Optifast, among others, while Dr. Reddy’s will offer brands like Rebalanz, Celevida, and Antoxid. The JV is expected to be operational by the second quarter of the 2025 financial year.

Speaking on this, Suresh Narayanan, chairman and managing director, Nestlé India stated, “I am very happy to share that we are entering into a joint venture with Dr. Reddy’s Laboratories. This joint venture is another important step in allowing us to bring our science-backed nutritional solutions to more people across the country. Dr. Reddy’s is a trusted name in the pharmaceutical space and shares our commitment to provide access to high-quality products. This joint venture will enable us to build a robust retail and distribution network to take our brands closer to consumers and make a meaningful difference to improve the quality of life.”

Commenting on the same, M.V. Ramana, chief executive officer – Branded Markets (India & Emerging Markets), Dr. Reddy stated, “This joint venture is a novel approach by two companies that have a shared purpose of good health. We are pleased to partner with Nestlé India to bring innovations from the Nestlé Health Science global portfolio to consumers in India. This novel approach of leveraging mutually complementary strengths of both parent companies will enable better access and affordability for consumers.”
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Nestle IndiaDr ReddysNutraceuticalIndian companies

First Published: Apr 25 2024 | 6:16 PM IST

Next Story